These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention. Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Barry A; Tapily A; Nikiema F; Yerbanga S; Coumare S; Thera I; Traore A; Milligan P; Tinto H; Doumbo O; Ouedraogo JB; Greenwood B N Engl J Med; 2019 Jun; 380(23):2197-2206. PubMed ID: 30699301 [TBL] [Abstract][Full Text] [Related]
6. The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01 Cairns M; Barry A; Zongo I; Sagara I; Yerbanga SR; Diarra M; Zoungrana C; Issiaka D; Sienou AA; Tapily A; Sanogo K; Kaya M; Traore S; Diarra K; Yalcouye H; Sidibe Y; Haro A; Thera I; Snell P; Grant J; Tinto H; Milligan P; Chandramohan D; Greenwood B; Dicko A; Ouedraogo JB BMC Med; 2022 Oct; 20(1):352. PubMed ID: 36203149 [TBL] [Abstract][Full Text] [Related]
7. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso. Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. ACCESS-SMC Partnership Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936 [TBL] [Abstract][Full Text] [Related]
9. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention. Yaro JB; Tiono AB; Ouedraogo A; Lambert B; Ouedraogo ZA; Diarra A; Traore A; Lankouande M; Soulama I; Sanou A; Worrall E; Agboraw E; Sagnon N; Ranson H; Churcher TS; Lindsay SW; Wilson AL Sci Rep; 2022 Jan; 12(1):1402. PubMed ID: 35082312 [TBL] [Abstract][Full Text] [Related]
10. Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial. NDiaye JL; Cissé B; Ba EH; Gomis JF; Ndour CT; Molez JF; Fall FB; Sokhna C; Faye B; Kouevijdin E; Niane FK; Cairns M; Trape JF; Rogier C; Gaye O; Greenwood BM; Milligan PJ PLoS One; 2016; 11(10):e0162563. PubMed ID: 27764102 [TBL] [Abstract][Full Text] [Related]
11. The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine. Sagara I; Zongo I; Cairns M; Yerbanga RS; Mahamar A; Nikièma F; Tapily A; Sompougdou F; Diarra M; Zoungrana C; Issiaka D; Haro A; Sanogo K; Aziz Sienou A; Kaya M; Traore S; Thera I; Diarra K; Dolo A; Kuepfer I; Snell P; Milligan P; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B Clin Infect Dis; 2022 Sep; 75(4):613-622. PubMed ID: 34894221 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. Beshir KB; Muwanguzi J; Nader J; Mansukhani R; Traore A; Gamougam K; Ceesay S; Bazie T; Kolie F; Lamine MM; Cairns M; Snell P; Scott S; Diallo A; Merle CS; NDiaye JL; Razafindralambo L; Moroso D; Ouedraogo JB; Zongo I; Kessely H; Doumagoum D; Bojang K; Ceesay S; Loua K; Maiga H; Dicko A; Sagara I; Laminou IM; Ogboi SJ; Eloike T; Milligan P; Sutherland CJ Lancet Infect Dis; 2023 Mar; 23(3):361-370. PubMed ID: 36328000 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries. Cairns M; Ceesay SJ; Sagara I; Zongo I; Kessely H; Gamougam K; Diallo A; Ogboi JS; Moroso D; Van Hulle S; Eloike T; Snell P; Scott S; Merle C; Bojang K; Ouedraogo JB; Dicko A; Ndiaye JL; Milligan P PLoS Med; 2021 Sep; 18(9):e1003727. PubMed ID: 34495978 [TBL] [Abstract][Full Text] [Related]
14. Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3-59 months in Nigeria: A propensity score-matched analysis. Huang S; Baker K; Ibinaiye T; Oresanya O; Nnaji C; Richardson S Trop Med Int Health; 2024 Aug; 29(8):668-679. PubMed ID: 38842452 [TBL] [Abstract][Full Text] [Related]
15. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial. Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323 [TBL] [Abstract][Full Text] [Related]
16. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood BM; Diallo DA PLoS One; 2011; 6(8):e23391. PubMed ID: 21858097 [TBL] [Abstract][Full Text] [Related]
17. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399 [TBL] [Abstract][Full Text] [Related]
18. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali. Cairns ME; Sagara I; Zongo I; Kuepfer I; Thera I; Nikiema F; Diarra M; Yerbanga SR; Barry A; Tapily A; Coumare S; Milligan P; Tinto H; Ouédraogo JB; Chandramohan D; Greenwood B; Djimde A; Dicko A PLoS Med; 2020 Aug; 17(8):e1003214. PubMed ID: 32822362 [TBL] [Abstract][Full Text] [Related]
20. Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study. Thompson HA; Hogan AB; Walker PGT; Winskill P; Zongo I; Sagara I; Tinto H; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B; Cairns M; Ghani AC Lancet Glob Health; 2022 Dec; 10(12):e1782-e1792. PubMed ID: 36400084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]